Metabolic Disorders Therapeutics Market Poised to Grow from US$74.97 Billion in 2024 to US$157.65 Billion by 2033 | DataM Intelligence

According to DataM Intelligence, Metabolic Disorders Therapeutics Market Size was valued at US$74.97 billion in 2024 and is ...

Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...

Researchers decode the chemistry behind a deadly genetic disorder

Northeastern University researchers used an original machine learning tool to predict how genetic mutations cause a rare ...
eLife

Kinesin-1 conformational dynamics are controlled by a cargo-sensitive TPR switch

Kinesin-1 is a dynamic heterotetrameric assembly of two heavy and two light chains (KHC and KLC) that mediates microtubule-based intracellular transport of many different cargoes. The complex adopts a ...